|19.19||+2.18||+12.82%||Vol 1.29M||1Y Perf -28.41%|
|Jun 5th, 2020 16:00 DELAYED|
|- -%||- -%|
|Target Price||18.20||Analyst Rating||Hold 3.10|
|Potential %||-5.16||Finscreener Ranking||+ 39.83|
|Insiders Trans % 3/6/12 mo.||-/-/43||Value Ranking||★+ 45.39|
|Insiders Value % 3/6/12 mo.||-/-/95||Growth Ranking||+ 33.86|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/95||Income Ranking||— -|
|Market Cap||1.64B||Earnings Rating||Strong Sell|
|Price Range Ratio 52W %||55.52||Earnings Date||7th May 2020|
Today's Price Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||0.48|
|EPS Growth Next 5 Years %||10.00|
|Avg. Weekly Volume||1.21M|
|Avg. Monthly Volume||1.31M|
|Avg. Quarterly Volume||1.40M|
Mednax Inc. (NYSE: MD) stock closed at 19.19 per share at the end of the most recent trading day (a 12.82% change compared to the prior day closing price) with a volume of 1.29M shares and market capitalization of 1.64B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 11875 people. Mednax Inc. CEO is Roger J. Medel.
The one-year performance of Mednax Inc. stock is -28.41%, while year-to-date (YTD) performance is -30.95%. MD stock has a five-year performance of -72.8%. Its 52-week range is between 7.37 and 28.66, which gives MD stock a 52-week price range ratio of 55.52%
Mednax Inc. currently has a PE ratio of -, a price-to-book (PB) ratio of 0.89, a price-to-sale (PS) ratio of 0.40, a price to cashflow ratio of 5.00, a PEG ratio of 2.32, a ROA of -25.40%, a ROC of -26.90% and a ROE of -59.69%. The company’s profit margin is -36.30%, its EBITDA margin is -31.70%, and its revenue ttm is $3.51 Billion , which makes it $41.08 revenue per share.
Of the last four earnings reports from Mednax Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.48 for the next earnings report. Mednax Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Mednax Inc. is Hold (3.1), with a target price of $18.2, which is -5.16% compared to the current price. The earnings rating for Mednax Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Mednax Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Mednax Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 20.01, ATR14 : 1.16, CCI20 : 210.30, Chaikin Money Flow : 0.17, MACD : 1.08, Money Flow Index : 72.92, ROC : 24.77, RSI : 72.37, STOCH (14,3) : 88.47, STOCH RSI : 1.00, UO : 60.65, Williams %R : -11.53), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Mednax Inc. in the last 12-months were: Dominic J. Andreano (Option Excercise at a value of $0), John C. Pepia (Option Excercise at a value of $0), Michael B. Fernandez (Buy at a value of $8 079 697), Pascal J. Goldschmidt (Sold 10 000 shares of value $218 453 )
Copyright (c) 2020. All rights reserved. Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.com, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.